Redwire Lands $25M NASA Contract for ISS Support Services
ByAinvest
Friday, Aug 29, 2025 7:19 pm ET1min read
RDW--
The contract includes a recent $2.5 million task order from NASA's In Space Production Applications (InSPA) program, which will support additional drug development investigations on the ISS using Redwire's PIL-BOX technology [1]. Redwire will provide turnkey services to manage, integrate, and facilitate experiments and support on-orbit operations for NASA-funded research investigations aboard the ISS.
Redwire's capabilities are intended to support the diverse set of life and materials sciences research investigations that NASA processes every year. The company's expertise in microgravity research and development technologies has enabled it to support notable research partners such as Bristol Myers Squibb, Eli Lilly and Company, and Butler University [2].
Redwire's PIL-BOX technology, which allows for the growth of crystals in microgravity, has been a key asset in advancing space biotechnology and pharmaceutical development. The company recently formed SpaceMD, a new entity focused on growing seed crystals in orbit for use on Earth to create new and reformulated pharmaceuticals [2].
This contract underscores Redwire's role as a global leader in space and defense technology solutions, with a strong focus on biotechnology and microgravity research. The company's approximately 1,300 employees are committed to delivering innovative space and airborne platforms that transform multi-domain operations [2].
References:
[1] https://www.marketscreener.com/news/redwire-receives-25-million-single-award-idiq-contract-by-nasa-to-provide-biotechnology-and-support-ce7c50dfd18cff21
[2] https://redwirespace.com/newsroom/redwire-awarded-25-million-single-award-idiq-contract-by-nasa-to-provide-biotechnology-and-support-on-orbit-operations-aboard-the-international-space-station/
Redwire has been awarded a $25M IDIQ contract by NASA for a five-year period to provide biotechnology facilities, on-orbit operations support, mission integration, and related services for the agency on the International Space Station. The contract has a $25M ceiling and Redwire was recently issued a $2.5M task order to support drug development investigations on the ISS using its PIL-BOX technology.
Redwire Corporation has been awarded a $25 million, five-year indefinite-delivery/indefinite-quantity (IDIQ) contract by NASA to provide biotechnology facilities, on-orbit operations support, mission integration, and related services for the International Space Station (ISS). This contract, with a ceiling of $25 million, was announced on August 28, 2025 [2].The contract includes a recent $2.5 million task order from NASA's In Space Production Applications (InSPA) program, which will support additional drug development investigations on the ISS using Redwire's PIL-BOX technology [1]. Redwire will provide turnkey services to manage, integrate, and facilitate experiments and support on-orbit operations for NASA-funded research investigations aboard the ISS.
Redwire's capabilities are intended to support the diverse set of life and materials sciences research investigations that NASA processes every year. The company's expertise in microgravity research and development technologies has enabled it to support notable research partners such as Bristol Myers Squibb, Eli Lilly and Company, and Butler University [2].
Redwire's PIL-BOX technology, which allows for the growth of crystals in microgravity, has been a key asset in advancing space biotechnology and pharmaceutical development. The company recently formed SpaceMD, a new entity focused on growing seed crystals in orbit for use on Earth to create new and reformulated pharmaceuticals [2].
This contract underscores Redwire's role as a global leader in space and defense technology solutions, with a strong focus on biotechnology and microgravity research. The company's approximately 1,300 employees are committed to delivering innovative space and airborne platforms that transform multi-domain operations [2].
References:
[1] https://www.marketscreener.com/news/redwire-receives-25-million-single-award-idiq-contract-by-nasa-to-provide-biotechnology-and-support-ce7c50dfd18cff21
[2] https://redwirespace.com/newsroom/redwire-awarded-25-million-single-award-idiq-contract-by-nasa-to-provide-biotechnology-and-support-on-orbit-operations-aboard-the-international-space-station/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet